| 1 |
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol, 2009, 27(9): 1485-1491.
|
| 2 |
Yuan BZ, Miller MJ, Keck CL, et al. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res, 1998, 58(10): 2196-2199.
|
| 3 |
Ko FC, Yeung YS, Wong CM, et al. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma. Liver Int, 2010, 30(1): 139-148.
|
| 4 |
Low JS, Tao Q, Ng KM, et al. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene, 2011, 30(16): 1923-1935.
|
| 5 |
Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol, 2008, 9(9): 690-701.
|
| 6 |
Grise F, Bidaud A, Moreau V. Moreau, Rho GTPases in hepatocellular carcinoma. Biochim Biophys Acta, 2009, 1795(2): 137-151.
|
| 7 |
Qiao F, Bowie JU. The many faces of SAM. Sci STKE, 2005, 2005(286): re7.
|
| 8 |
Kim TY, Healy KD, Der CJ, et al. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J Biol Chem, 2008, 283(47): 32 762-32 770.
|
| 9 |
Zhong D, Zhang J, Yang S, et al. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J Cell Sci, 2009, 122(Pt 3): 414-424.
|
| 10 |
Strauss JF 3rd, Kishida T, Christenson LK, et al. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol, 2003, 202(1-2): 59-65.
|
| 11 |
Zhang M, Liu P, Dwyer NK, et al. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J Biol Chem, 2002, 277(36): 33 300-33 310.
|
| 12 |
Li G, Du X, Vass WC, et al. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci U S A, 2011, 108(41): 17 129-17 134.
|
| 13 |
Ng IO, Liang ZD, Cao L, et al. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res, 2000, 60(23): 6581-6584.
|
| 14 |
Wong CM, Lee JM, Ching YP, et al. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res, 2003, 63(22): 7646-7651.
|
| 15 |
Zhou X, Zimonjic DB, Park SW, et al. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol, 2008, 32(6): 1285-1291.
|
| 16 |
Zhou X, Thorgeirsson SS, Popescu NC. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene, 2004, 23(6): 1308-1313.
|
| 17 |
Yuan BZ, Jefferson AM, Millecchia L, et al. Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells. Exp Cell Res, 2007, 313(18): 3868-3880.
|
| 18 |
Ogawa T, Tashiro H, Miyata Y, et al. Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. Am J Transplant, 2007, 7(2): 347-355.
|
| 19 |
段炜，顾勇，杨艳, 等. DBC1在肝癌组织中的表达及临床意义[J/CD]. 中华临床医师杂志：电子版, 2012, 6(9): 2370-2373.
|
| 20 |
Wu J, Li Y, Fan X, et al. Analysis of gene expression profile of periodontal ligament cells subjected to cyclic compressive force. DNA Cell Biol, 2011, 30(11): 865-873.
|
| 21 |
Roessler S, Long EL, Budhu A, et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology, 2012, 142(4): 957-966.e12.
|
| 22 |
Goodison S, Yuan J, Sloan D, et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res, 2005, 65(14): 6042-6053.
|
| 23 |
Wong CM, Yam JW, Ching YP, et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res, 2005, 65(19): 8861-8868.
|
| 24 |
Holeiter G, Heering J, Erlmann P, et al. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res, 2008, 68(21): 8743-8751.
|
| 25 |
Durkin ME, Avner MR, Huh CG, et al. DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett, 2005, 579(5): 1191-1196.
|
| 26 |
Dong X, Zhou G, Zhai Y, et al. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. Cancer Epidemiol, 2009, 33(3-4): 265-270.
|
| 27 |
Xue W, Krasnitz A, Lucito R, et al. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev, 2008, 22(11): 1439-1444.
|
| 28 |
Kim TY, Jong HS, Song SH, et al. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene, 2003, 22(25): 3943-3951.
|
| 29 |
Yuan BZ, Durkin ME, Popescu NC. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet, 2003, 140(2): 113-117.
|
| 30 |
Banaudha K, Kaliszewski M, Korolnek T, et al. MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology, 2011, 53(1): 53-61.
|